Holen Sie sich die Stockscreener-App
0.00
100.00%
-4.74
Schlusskurs vom Vortag:
$4.74
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$187.37M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.32M
KGV:
0.00
EPS:
-12.7107
Netto-Cashflow:
$-7.30M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$9.08
Tharimmune Inc Stock (THAR) Company Profile
Firmenname
Tharimmune Inc
Sektor
Branche
Telefon
302-743-2995
Adresse
1200 ROUTE 22 EAST, BRIDGEWATER
Compare THAR vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
THAR
Tharimmune Inc
|
0.00 | 187.37M | 0 | -9.32M | -7.30M | -12.71 |
VRTX
Vertex Pharmaceuticals Inc
|
451.23 | 113.44B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
779.25 | 81.68B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
738.25 | 45.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
332.35 | 43.88B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
164.16 | 35.25B | 606.42M | -1.28B | -997.58M | -6.403 |
Tharimmune Inc Aktie (THAR) Neueste Nachrichten
RSI Check: Does Tharimmune Inc have strong EBITDA marginsGlobal Markets & Free Community Supported Trade Ideas - baoquankhu1.vn
Dow Update: Is Tharimmune Inc stock showing strong momentumTake Profit & Precise Buy Zone Identification - baoquankhu1.vn
Buyback Watch: Does Tharimmune Inc offer margin of safety2026 Final Week & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Pullback Watch: Will Tharimmune Inc benefit from geopolitical trendsMarket Performance Report & Free Community Consensus Stock Picks - baoquankhu1.vn
Growth Report: Is now the right time to enter Tharimmune IncWeekly Market Summary & AI Powered Market Trend Analysis - baoquankhu1.vn
Articles from Tharimmune, Inc. - FinancialContent
Revenue Check: What are analysts price targets for Tharimmune IncWatch List & Stock Market Timing Techniques - baoquankhu1.vn
Market Review: Is Tharimmune Inc still a buy after recent gainsBear Alert & Free Reliable Trade Execution Plans - baoquankhu1.vn
Volume Recap: Whats the beta of Tharimmune Inc stock2026 Movers & Long Hold Capital Preservation Tips - baoquankhu1.vn
If You Invested $1,000 in Tharimmune Inc (THAR) - Stock Titan
Tharimmune names Mark Wendland board chair, appoints Angela Radkowski as COO - MSN
Tharimmune (NASDAQ:THAR) Shares Down 0.5%Time to Sell? - marketbeat.com
Tharimmune’s TH104 Lifted Shares, But Dilution Risk Still Looms - Finimize
Market Overview: Is Tharimmune Inc. a cyclical or defensive stock2026 Major Catalysts & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Weekly Trades: What are analysts price targets for Tharimmune IncEarnings Growth Report & High Accuracy Buy Signal Tips - baoquankhu1.vn
Momentum Shift: What are analysts price targets for Tharimmune Inc2025 Winners & Losers & Technical Pattern Alert System - baoquankhu1.vn
Patterns Watch: Is Tharimmune Inc a stock for growth or value investors2025 Buyback Activity & Proven Capital Preservation Methods - baoquankhu1.vn
Risk Report: Why is Tharimmune Inc stock going upQuarterly Trade Summary & Short-Term High Return Strategies - baoquankhu1.vn
Tharimmune Reports Pharmacokinetic Simulation Results for TH104 as Prophylaxis Against Respiratory Depression from Fentanyl and Ultrapotent Opioids, Highlighting Potential Superiority Over Existing Treatments - Montgomery Advertiser
Canton Strategic Holdings CEO joins Canton Foundation board By Investing.com - Investing.com Canada
Canton Strategic Holdings CEO joins Canton Foundation board - Investing.com
Canton Strategic Holdings Inc enters amended sales agreement with Clear Street and Virtu AmericasSEC filing - marketscreener.com
Canton Strategic Holdings amends stock sales agreement, adds Virtu Americas as agent - Investing.com
Canton Strategic Holdings, Inc. chairman and CEO Mark Wendland elected to Canton Foundation board - marketscreener.com
Canton Strategic Holdings, Inc. Chairman and CEO Mark Wendland Elected to Canton Foundation Board - marketscreener.com
Volume Recap: Is Tharimmune Inc stock undervalued right nowWeekly Risk Summary & Fast Gain Swing Alerts - baoquankhu1.vn
CNTN Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
THAR Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
THAR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Tharimmune, Inc. (CNTN) Stock Live Price, Chart & News - CoinCodex
Does Tharimmune Inc. offer margin of safety2025 Key Highlights & Free Daily Entry Point Trade Alerts - mfd.ru
Tharimmune (NASDAQ:THAR) Trading Up 3.8%Time to Buy? - MarketBeat
Death Cross: Is Tharimmune Inc a cyclical or defensive stockM&A Rumor & Weekly High Return Stock Opportunities - baoquankhu1.vn
Tharimmune Rebrands as Canton Strategic Holdings, Updates Ticker - The Globe and Mail
Tharimmune Rebrands as Canton Strategic, Ticker CNTN - National Today
Canton Strategic Holdings (NASDAQ: CNTN) rebrands and highlights $545M crypto strategy - Stock Titan
Is Canton’s price set to explode amid Tharimmune’s rebrand? - Bitget
Tharimmune rebrands to Canton Strategic Holdings with new NASDAQ ticker - Investing.com Australia
Tharimmune rebrands as Canton Strategic Holdings with new ticker CNTN By Investing.com - Investing.com Nigeria
Tharimmune rebrands to Canton Strategic Holdings with new NASDAQ ticker By Investing.com - Investing.com South Africa
Tharimmune rebrands as Canton Strategic Holdings with new ticker CNTN - Investing.com
Tharimmune Inc rebrands to Canton Strategic Holdings - marketscreener.com
Tharimmune, Inc. Announces Corporate Rebrand to Canton Strategic Holdings, Inc., Marking Milestone in Canton Network Digital Asset Treasury Strategy - marketscreener.com
Is Tharimmune Inc. a potential multi baggerQuarterly Portfolio Summary & Long-Term Growth Plans - mfd.ru
Pharma News: Is VNOM a good stock for dollar cost averagingPortfolio Gains Summary & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Investment Report: Is Tharimmune Inc a potential multi baggerJuly 2025 Snapshot & Entry Point Confirmation Signals - baoquankhu1.vn
Will Tharimmune Inc. benefit from geopolitical trendsWeekly Stock Summary & Daily Stock Trend Watchlist - mfd.ru
Does Tharimmune Inc. have strong EBITDA marginsJuly 2025 Momentum & Stepwise Entry and Exit Trade Signals - mfd.ru
Is Tharimmune Inc. stock showing strong momentumJuly 2025 PostEarnings & Intraday High Probability Setup Alerts - mfd.ru
Tharimmune appoints new chairman and COO to advance digital asset strategy - Investing.com Canada
Tharimmune Elects CEO Mark Wendland as Chair, Names Angela Radkowski as COO - marketscreener.com
Finanzdaten der Tharimmune Inc-Aktie (THAR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.44%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):